AQEMIA

𝗔𝗤𝗘𝗠𝗜𝗔 𝗶𝘀 𝗲𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴, 𝗮𝗻𝗱 𝘄𝗲'𝗿𝗲 𝗵𝗶𝗿𝗶𝗻𝗴! 🚀 🌟 We're looking for talented individuals to join us on our mission to accelerate drug discovery and bring transformative medicines to patients 💊 Here’s a glimpse of some key roles we’ve just opened: ▶ Drug Discovery - Program Leader  ▶ Medicinal Chemist ▶ Senior Drug Hunter ▶ DevSecOps Engineer If you're passionate about innovation in healthcare and want to be part of a cutting-edge team, check out the details ➡ https://lnkd.in/e2raz4Zd Join us and shape the future of medicine! #Hiring #DrugHunter #MedicinalChemist #ComputationalChemist #ProgramLeader #DrugDiscovery  ↔ Nicolas Serva

Glad to read Denis Barrier's ideas on how large corporates and startups can fuel each other to build global champions. I do share with Denis that to build global leaders in artificial intelligence, close collaboration between startups and large corporations is essential. Startups bring innovation and agility, while big companies offer resources and sector expertise. Denis uses the partnerships between Sanofi and AQEMIA 😊 , or CMA CGM and Mistral AI, to illustrate how synergies enhance innovation and competitiveness, ultimately to redefine the rules of the game and create global AI leaders. cc Cathay Innovation, La French Tech, Emmanuelle Martiano Rolland, Julie Huguet, Clara Chappaz

📢 Alert - I'm looking for a Senior Talent Acquisition Specialist based in Paris! I've been at AQEMIA for just two months, and I can already say—it’s a place like no other, starting with our outstanding team! 💡 Why Choosing Us? - We’re combining cutting-edge AI and physics to revolutionize drug discovery with a clear mission: find drugs. - We are growing, and as one of LinkedIn’s Top Startups of 2024, we’re on an exciting journey where innovation meets purpose. - Your impact will be tangible. You’ll help scale teams of brilliant minds and shape AQEMIA’s future together. We have a solid recruitment plan to get there, and this role is about making it happen, bringing in niche scientific outstanding people. 💫 If you’re up for a meaningful challenge, let’s chat or apply - link to the JD in the comments ⬇️ #Hiring #TalentAcquisition #AI #MissionDriven #TopStartup #JoinUs

⭐ We’re thrilled to welcome Olivier Bezençon as our new VP Medicinal Chemistry! ⭐ With 25 years of experience, Olivier has successfully led drug discovery from inception to identifying development candidates. Before joining AQEMIA, Olivier was Head of CNS Chemistry at Idorsia Pharmaceuticals Ltd, where he managed a team of 18 researchers. Prior to that, he held a senior leadership role at Actelion (now Janssen Pulmonary Hypertension), advancing multiple preclinical candidates. As we expand our research programs and approach the clinic, Olivier will play a key role in developing AQEMIA's Medicinal Chemistry activities. By leveraging his extensive expertise and our cutting-edge physics algorithms, we aim to build a robust pipeline of clinical candidates.  Welcome aboard, Olivier 🚀 #MedicinalChemistry #DrugDiscovery #biotech #NewAddition

💊 Algorithmes innovants, partenariats stratégiques et recherche accélérée : AQEMIA mise sur l’#IA et la physique #quantique pour transformer le développement de #médicaments. Fondée en 2019, AQEMIA s'appuie sur des algorithmes uniques pour identifier les molécules les plus prometteuses dans l'avancée des traitements. Et ce, en quelques minutes seulement, là où les méthodes traditionnelles prennent plusieurs heures ⏱️❗ Emmanuelle Martiano Rolland, sa co-fondatrice et COO, revient sur l’évolution sur les prochaines étapes de développement clinique et les ambitions d'AQEMIA pour lancer de nouveaux programmes de #recherche ! ➡️ https://lnkd.in/eQ_2mgWU

⭐ AQEMIA appoints Dr Veronique Birault, Ph.D., as Vice President, Translational Sciences ⭐ We are pleased to announce the appointment of Dr Veronique Birault as our VP Translational Sciences. In this key role, Dr. Birault will oversee AQEMIA's translational sciences, driving the identification of promising therapeutic programs for patients. "We are thrilled to welcome Dr. Véronique Birault at AQEMIA as we approach a pivotal phase in our journey — bringing our molecules closer to the clinic to prove their potential in patients" said Maximilien Levesque, our CEO and co-founder. “Her extensive experience in translational sciences and therapeutic development will be instrumental to build the right portfolio of drug discovery programs for patients". Dr. Birault joins AQEMIA with over 20 years of experience in drug discovery and translational science, having held leadership roles in pharmaceutical companies and academic institutions. Most recently, she served as Director of Translation at The Francis Crick Institute, where she led initiatives to bridge fundamental science with clinical applications, resulting in 11 spin-outs across areas like cell therapy, vaccines, and small molecule therapeutics. Prior to that, she held strategic positions at GSK, guiding early-stage research and development across multiple therapeutic areas.  "I am incredibly privileged to be joining the amazing team that Maximilien Levesque and Emmanuelle Martiano Rolland are building at AQEMIA. With such a talented group of colleagues and an innovative portfolio" said Dr. Birault.  #TranslationalSciences #DrugDiscovery #NewAddition #Biotech

"It's as if we had a physics professor teaching physics to our generative AI. The AI invents drug candidates, and the professor tells it whether they are stupid or interesting, and if so to continue in that direction until we are satisfied enough with the molecules found by the #generativeAI to have them manufactured and then tested in the laboratory" explains Maximilien Levesque, our CEO & Cofounder. Building on a unique blend of theoretical physics and chemistry, we’re leveraging advanced technology to accelerate the development of breakthrough treatments. Curious about how a drug actually stops a disease? 💊 Check out the full Brut. video where Emmanuelle Martiano Rolland breaks it down ↘ https://lnkd.in/eAWZEBPT Thanks Tibor for visiting us and glad to share this vision of healthcare innovation with Bpifrance, whose support has been invaluable!  #DrugDiscovery #AI #Physics #TechBio #Big10

Thank you Institut Choiseul for selecting me in the "40 under 40 in healthcare" This is a great recognition that I share with Maximilien Levesque on accelerating drug discovery with GenAI combined to Deep Physics, with our stellar AQEMIA team ! Maddyness #ChoiseulTop40Santé #Healthcare #Deeptech https://lnkd.in/eKqMjMzZ ;

{Press Review} : AI Feature for l'Opinion : the 100 who are powering AI in Europe In an interview with l'Opinion, AQEMIA's co-founder and COO, Emmanuelle Martiano Rolland, shared insights into our mission to combine generative AI with theoretical physics in the quest for breakthrough cancer treatments. The article also highlights our partnership with Sanofi and how our technology is already showing promising results in preclinical studies. While we’re proud of our French roots 🇫🇷 , our mission is global: advancing research and therapies to benefit patients worldwide 🌎 Thank you l'Opinion and Grégoire Arnould-Cordier for this insightful conversation ⤵  https://lnkd.in/e7eKcRVu #AI #DrugDiscovery #Biotech #Healthcare #lOdysseedelIA

Bravo La French Tech ! Hier soir était la rentrée de la Mission French Tech, avec la belle annonce par la secrétaire d’Etat chargée de l’Intelligence artificielle et du Numérique Clara Chappaz, de celle qui lui succède à ce poste : Julie Huguet. J'ai eu l'honneur d'être invité à la table ronde qui a suivi l'annonce, avec Julie et Anne Vincent-Salomon (Institut Curie) et animée par Charlie Perreau de Les Echos. On a parlé des ponts entre la recherche et entrepreneuriat, donc de #deeptech, d' #IA … et de souveraineté, cette souveraineté positive, celle de l'investissement en soi et en les autres, celle de la construction des champions de demains, de la compétition par le dépassement de soi et l'exploration de l'inconnu (de la recherche ! 😇). J'étais très heureux d'être parmi vous. Merci Lucie Finet pour ton invitation et toute la French Tech pour votre optimisme et votre confiance.